• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ixlayer Launches COVID-19 testing platform

Ixlayer Launches COVID-19 testing platform

March 25, 2020 By Sean Whooley

Ixlayer announced today that it is adapting its established testing platform for COVID-19-specific content and user flows to allow for quick connection in the delivery of coronavirus testing.

The San Francisco-based company said its platform already encompasses complex security components and is now adapted to the coronavirus-related content and flows that allow physicians, health systems, organizations and university groups to quickly connect with partnering labs for COVID-19 testing.

Using global responses to the virus as its jumping-off point, Ixlayer said it adjusted its platform to ensure that  it addressed issues such as:

  • Scalable technology to support multiple labs and providers across all states.
  • Telemedicine infrastructure so ordering physicians can connect with patients at home.
  • Secure online (HIPAA-compliant) collection of patient health screening and eligibility data.
  • Third-party telemedicine physician networks to support high demand.
  • Ability to schedule COVID-19 sample collection for patient drive-through.

The coronavirus test platform is designed to gather real-time data to allow the Centers for Disease Control and Prevention (CDC) or others to identify trends in disease transmission. Using CDC and World Health Organization (WHO) guidelines to develop the platform, Ixlayer said it set out to give patients accurate, up-to-date educational materials.

Ixlayer CEO Pouria Sanae said in a news release that the company hopes employee groups can order bulk testing to clear employees so that only the healthy are in essential positions.

“Bringing a new test online can be complicated and time-consuming without technology solutions,” Sanae said. “Thankfully, the Ixlayer platform has been efficiently delivering precision health testing across the U.S. using the telehealth model for several years, so we already have the needed security and infrastructure in place. I am proud of my team’s swift modifications to the Ixlayer platform, ensuring the additional measures needed to scale COVID-19 testing nationally are in place.”

Filed Under: Business/Financial News, Diagnostics, Featured Tagged With: coronavirus, COVID-19, Ixlayer

More recent news

  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire
  • Medtronic wins CE mark for LigaSure sealing tech for Hugo surgical robot

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy